Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
A Trial of SHR0302Base in Patients With Vitiligo
Official title: A Multicenter, Randomized, Double-blind, Parallel, Excipient-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of SHR0302Base in Subjects With Nonsegmental Vitiligo
Status: Closed to new participants
Description:
The purpose of this study is to evaluate the efficacy and safety of SHR0302Base in participants with nonsegmental vitiligo.
Phase: Phase 2.
What is being studied: drugs — SHR0302Base gel, SHR0302Base gel placebo.
Who can take part: ages 18 Years to 75 Years, 155 participants planned.
Enrollment status: the registry has not updated this study since its planned completion date, so its current status is unclear. The study started 13 February 2025 and was due to finish 01 April 2026.
Source: ClinicalTrials.gov, NCT06790862 (https://clinicaltrials.gov/study/NCT06790862).
Start date: February 13, 2025
Completion date: April 01, 2026
Organizer: Jiangsu HengRui Medicine Co., Ltd.
Link: https://clinicaltrials.gov/study/NCT06790862
The registry does not list a contact for this study. Use the link above to reach the study record on ClinicalTrials.gov.
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Pyrostegia venusta as a folk medicine for vitiligo?
Pyrostegia venusta, also known as “flame vine” or “cipó-de-são-joão,” is a neotropical evergreen vine native to Brazil. It thrives in fields, coastal areas, forest edges, and ro...
- Which diseases most commonly accompany vitiligo?
Vitiligo is rarely an isolated event. Because it involves an overactive immune system, it often coexists with other autoimmune disorders. According to extensive 10-year clinical...
- Is there a link between vitiligo and depression?
Depression and anxiety are often linked with vitiligo, significantly impacting a person’s quality of life. The connection stems from the shared origin of the skin and brain duri...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.